Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M75,774Revenue (TTM) $M24,766Net Margin (%)11.8Altman Z-Score1.5
Enterprise Value $M87,721EPS (TTM) $1.2Operating Margin %17.0Piotroski F-Score7
P/E(ttm)26.6Beneish M-Score-2.6Pre-tax Margin (%)12.6Higher ROA y-yY
Price/Book4.910-y EBITDA Growth Rate %-0.2Quick Ratio0.7Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %-17.9Current Ratio0.8Lower Leverage y-yN
Price/Free Cash Flow30.0y-y EBITDA Growth Rate %25.6ROA % (ttm)5.1Higher Current Ratio y-yN
Dividend Yield %4.7PEG--ROE % (ttm)17.0Less Shares Outstanding y-yY
Payout Ratio %121Shares Outstanding M2,530ROIC % (ttm)15.6Gross Margin Increase y-yY

Gurus Latest Trades with AZN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AZNDodge & Cox 2016-03-31 Add0.39%$27.95 - $33.95
($30.11)
$ 29.95-1%Add 121.19%26,049,650
AZNNWQ Managers 2016-03-31 Reduce$27.95 - $33.95
($30.11)
$ 29.95-1%Reduce -1.83%506,785
AZNKen Fisher 2016-03-31 Add$27.95 - $33.95
($30.11)
$ 29.95-1%Add 5.33%233,409
AZNDodge & Cox 2015-12-31 Buy 0.39%$30.47 - $34.77
($32.84)
$ 29.95-9%New holding11,777,132
AZNKen Fisher 2015-12-31 Add0.01%$30.47 - $34.77
($32.8)
$ 29.95-9%Add 692.95%221,606
AZNNWQ Managers 2015-12-31 Add0.01%$30.47 - $34.77
($32.84)
$ 29.95-9%Add 5.24%516,215
AZNNWQ Managers 2015-09-30 Add0.09%$30.28 - $34.54
($32.89)
$ 29.95-9%Add 60.04%490,535
AZNMario Gabelli 2015-09-30 Sold Out $30.28 - $34.54
($32.89)
$ 29.95-9%Sold Out0
AZNKen Fisher 2015-09-30 Buy $30.28 - $34.54
($32.89)
$ 29.95-9%New holding27,947
AZNDavid Dreman 2015-06-30 Sold Out -0.16%$31.86 - $36.68
($34.25)
$ 29.95-13%Sold Out0
AZNNWQ Managers 2015-06-30 Add0.12%$31.86 - $36.68
($34.25)
$ 29.95-13%Add 486.45%306,510
AZNMario Gabelli 2015-06-30 Reduce$31.86 - $36.68
($34.25)
$ 29.95-13%Reduce -28.81%8,400
AZNDavid Dreman 2015-03-31 Reduce-0.01%$32.22 - $36.35
($34.77)
$ 29.95-14%Reduce -4.43%54,978
AZNNWQ Managers 2015-03-31 Reduce-0.01%$32.22 - $36.35
($34.77)
$ 29.95-14%Reduce -21.34%104,530
AZNMario Gabelli 2015-03-31 Reduce$32.22 - $36.35
($34.77)
$ 29.95-14%Reduce -40.70%23,600
AZNDavid Dreman 2014-12-31 Reduce-0.51%$33.58 - $37.69
($35.82)
$ 29.95-16%Reduce -75.42%57,528
AZNGeorge Soros 2014-12-31 Sold Out -0.08%$33.58 - $37.69
($35.82)
$ 29.95-16%Sold Out0
AZNMario Gabelli 2014-12-31 Reduce-0.01%$33.58 - $37.69
($35.82)
$ 29.95-16%Reduce -52.51%39,800
AZNNWQ Managers 2014-12-31 Add$33.58 - $37.69
($35.82)
$ 29.95-16%Add 3.05%132,880
AZNCharles Brandes 2014-09-30 Sold Out -0.35%$34.25 - $38.16
($36.64)
$ 29.95-18%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AZN is held by these investors:


News about AZN:

Articles On GuruFocus.com
Dividend and Value Opportunities in the Large-Cap Pharmaceutical Space Apr 05 2016 
Francis Chou Raises Stake in Resolute Forest Products Mar 20 2016 
Signature Select Canadian Fund Second Quarter 2015 Market Commentary Sep 22 2015 
Francis Chou Doubles Stake in AstraZeneca Aug 11 2015 
Last Month Insiders Bought Over $300 Million Of This Biotech Jun 26 2015 
Guru Stocks at 52-Week Lows: XOM, WMT, CVX, AZN, COP Jun 21 2015 
Amgen And AstraZeneca’s Deal On Psoriasis Drug Faces Termination May 27 2015 
Johnson & Johnson A Good Investment Despite Current Lows May 14 2015 
Vanguard Adds to Four of Its Largest Stakes May 04 2015 
HealthCare Stocks That Can Make Investors Healthier Apr 08 2015 

More From Other Websites
Get your portfolio ready for Brexit by buying Imperial Brands plc and AstraZeneca plc May 26 2016
3 growth greats for your shares portfolio! AstraZeneca plc, Diageo plc and Wizz Air Holdings plc May 25 2016
Why AstraZeneca plc and Shire plc are 2 growth stars May 24 2016
Rlypsa Stock Pops on New Data and a Huge Risk May 23 2016
Are AstraZeneca plc, Eco Animal Health Group plc and Advanced Medical Solutions Group plc the top... May 23 2016
[$$] China Drug Deal Will Slash Prices of Three Top-Selling Treatments May 20 2016
[$$] China Drug Deal Will Slash Prices of Top Treatments May 20 2016
China slashes GSK, AstraZeneca drug prices in cost-cutting drive May 20 2016
8 Stocks on the Move After ASCO Cancer Abstracts May 19 2016
AstraZeneca Highlights Continued Progress of Oncology Pipeline at ASCO 2016 Leadership in DNA Damage... May 19 2016
AstraZeneca plc goes ‘nuclear’ on R&D spend to double sales May 19 2016
Europe close: Banks lead gains May 18 2016
FTSE 100 slips as Burberry earnings, U.S. rate-hike prospects weigh May 18 2016
AstraZeneca's Severe Asthma Drug Positive in Phase III May 18 2016
4 Stunning 5%+ Yielders! AstraZeneca plc, TUI AG, Marston’s plc and Taylor Wimpey plc May 18 2016
FTSE 100 flops as Burberry earnings, U.S. rate-hike prospects weigh May 18 2016
Why is Neil Woodford so bullish on drugmakers GlaxoSmithKline plc, AstraZeneca plc and 4D Pharma... May 18 2016
Europe open: Stocks nudge lower amid US rate hike concerns May 18 2016
Insight - Pascal Soriot's big experiment: reinventing AstraZeneca May 18 2016
Pascal Soriot's big experiment: reinventing AstraZeneca May 18 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)